Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | DRD1 | P21728 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3008523 | 0.81 | CTSD (0.31) | — | |
| SCHEMBL18605788 | 0.75 | CYP3A4 (0.44) | CYP3A4TDP1DRD1ESR1ESR2 | |
| SCHEMBL1304633 | 0.75 | CYP3A4 (0.40) | CYP3A4TDP1DRD1ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL3662739 | 0.74 | CYP3A4 (0.43) | CYP3A4TDP1DRD1ESR1ESR2 | |
| Bromide SCHEMBL4318068 | 0.74 | CYP3A4 (0.43) | CYP3A4TDP1DRD1ESR1ESR2 | |
| SCHEMBL3408265 | 0.72 | CYP3A4 (0.41) | CYP3A4TDP1DRD1ESR1ESR2 | |
| SCHEMBL1258556 | 0.70 | CYP3A4 (0.75) | CYP3A4TDP1DRD1ESR1ESR2 | |
| SCHEMBL6886030 | 0.70 | CYP3A4 (0.75) | CYP3A4TDP1DRD1ESR1ESR2 | |
| SCHEMBL28390312 | 0.70 | CYP3A4 (0.75) | CYP3A4TDP1DRD1ESR1ESR2 | |
| SCHEMBL31539924 | 0.68 | CYP3A4 (0.71) | CYP3A4TDP1DRD1ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100197938-A1 | Process for producing indole compoud | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-08-05 | — | — | US | disclosed |
| US-20070083053-A1 | Process for producing indole compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-04-12 | — | — | US | disclosed |
| US-5700400-A | Method for producing a semiconducting material | NIPPON OIL CO., LTD. (JP) | 1997-12-23 | — | — | US | disclosed |
| US-5620531-A | Photovoltaic element | NIPPON OIL CO., LTD. (JP) | 1997-04-15 | — | — | US | disclosed |
| EP-0717451-A2 | Photovoltaic element | NIPPON OIL CO., LTD. (JP) | 1996-06-19 | — | — | EP | disclosed |
| EP-0630933-A2 | A method of producing a semiconducting material | NIPPON OIL CO. LTD. (JP) | 1994-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197938-A1 | Process for producing indole compoud | IDO1, IDO2, NOS2 | CYP3A4 27/4885TDP1 3383/4885DRD1 72/4885 |
| US-20070083053-A1 | Process for producing indole compound | IDO2, IDO1, TDO2 | CYP3A4 16/4885TDP1 3755/4885DRD1 391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.